Literature DB >> 11025694

Laparoscopic radical nephroureterectomy for upper tract transitional cell carcinoma: the Cleveland Clinic experience.

I S Gill1, G T Sung, M G Hobart, S J Savage, A M Meraney, D K Schweizer, E A Klein, A C Novick.   

Abstract

PURPOSE: We report our single institutional experience with retroperitoneal laparoscopic radical nephroureterectomy in patients with upper tract transitional cell carcinoma and compare results to those achieved by the open technique.
MATERIALS AND METHODS: A total of 77 patients underwent radical nephroureterectomy for pathologically confirmed upper tract transitional cell carcinoma. Of these patients 42 underwent laparoscopic nephroureterectomy from September 1997 through January 2000 and 35 underwent open surgery. All specimens were extracted intact. Of the laparoscopic group the juxtavesical ureter and bladder cuff were excised by our novel transvesical needlescopic technique in 27 and radical nephrectomy was performed retroperitoneoscopically in all 42. Data were compared retrospectively with 35 patients undergoing open radical nephroureterectomy from February 1991 through December 1999.
RESULTS: Laparoscopy was superior in regard to surgical time (3.7 versus 4.7 hours, p = 0.003), blood loss (242 versus 696 cc, p <0. 0001), specimen weight (559 versus 388 gm., p = 0.04), resumption of oral intake (1.6 versus 3.2 days, p = 0.0004), narcotic analgesia requirements (26 versus 228 mg., p <0.0001), hospital stay (2.3 versus 6.6 days, p <0.0001), normal activities (4.7 versus 8.2 weeks, p = 0.002) and convalescence (8 versus 14.1 weeks, p = 0.007). Complications occurred in 5 patients (12%) in the laparoscopic group, including open conversions in 2, and in 10 (29%) in the open group (p = 0.07). Followup was shorter in the laparoscopic group (11.1 versus 34.4 months, p <0.0001). The 2 groups were similar in regard to bladder recurrence (23% versus 37%, p = 0.42), local retroperitoneal or port site recurrence (0% versus 0%) and metastatic disease (8.6% versus 13%, p = 1.00). Mortality occurred in 2 patients (6%) in the laparoscopic group and 9 (30%) in the open group. Cancer specific survival (97% versus 87%) and crude survival (97% versus 94%) were similar between both groups (p = 0.59).
CONCLUSIONS: In patients with upper tract transitional cell carcinoma who are candidates for radical nephroureterectomy the retroperitoneal laparoscopic approach satisfactorily duplicates established technical principles of traditional open oncological surgery, while significantly decreasing morbidity from this major procedure. Short-term oncological and survival data of the laparoscopic technique are comparable to open surgery. Although long-term followup data are not yet available, it appears that laparoscopic radical nephroureterectomy may supplant open surgery as the standard of care in patients with muscle invasive or high grade upper tract transitional cell carcinoma.

Entities:  

Mesh:

Year:  2000        PMID: 11025694

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  28 in total

Review 1.  Retroperitoneal renal laparoscopy.

Authors:  Rajeev Kumar; Ashok K Hemal
Journal:  Int Urol Nephrol       Date:  2010-12-17       Impact factor: 2.370

2.  The laparoscopic nephrectomy learning curve: a single centre's development of a de novo practice.

Authors:  J Phillips; J W F Catto; V Lavin; D Doyle; D J Smith; K J Hastie; N E Oakley
Journal:  Postgrad Med J       Date:  2005-09       Impact factor: 2.401

3.  [Comparison of efficacy and safety between two different methods of nephroureterectomy in two centers].

Authors:  J F Wu; R C Lin; Y C Lin; W H Cai; Q G Zhu; D Fang; G Y Xiong; L Zhang; L Q Zhou; L F Ye; X S Li
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2019-08-18

4.  Treatment of upper tract urothelial carcinoma: a review of surgical and adjuvant therapy.

Authors:  Kalyan C Latchamsetty; Christopher R Porter
Journal:  Rev Urol       Date:  2006

5.  Systematic review of open versus laparoscopic versus robot-assisted nephroureterectomy.

Authors:  Emma Mullen; Kamran Ahmed; Ben Challacombe
Journal:  Rev Urol       Date:  2017

6.  Nephroureterectomy for transitional cell carcinoma - the value of pre-operative histology.

Authors:  Sudhanshu Chitale; Rashidi Mbakada; Stuart Irving; Neil Burgess
Journal:  Ann R Coll Surg Engl       Date:  2008-01       Impact factor: 1.891

7.  Robotic nephroureterectomy with partial duodenectomy for invasive ureteral tumor.

Authors:  Pankaj P Dangle; Stephen Moore; Ronney Abaza
Journal:  JSLS       Date:  2010 Jul-Sep       Impact factor: 2.172

8.  Laparoscopic nephroureterectomy and management of the distal ureter: a review of current techniques and outcomes.

Authors:  Davis P Viprakasit; Amanda M Macejko; Robert B Nadler
Journal:  Adv Urol       Date:  2009-01-08

9.  Comprehensive management of upper tract urothelial carcinoma.

Authors:  Georgios Koukourakis; Georgios Zacharias; Michael Koukourakis; Kiriaki Pistevou-Gobaki; Christos Papaloukas; Athanasios Kostakopoulos; Vassilios Kouloulias
Journal:  Adv Urol       Date:  2008-12-10

10.  Hand-assisted laparoscopic nephroureterectomy for upper urinary tract transitional cell carcinoma.

Authors:  Jay D Raman; Michael A Palese; Casey K Ng; Stephen A Boorjian; Douglas S Scherr; Joseph J Del Pizzo; R Ernest Sosa
Journal:  JSLS       Date:  2006 Oct-Dec       Impact factor: 2.172

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.